IMS MAXIMS Announced as Finalist in HealthInvestor Awards

IMS MAXIMSIMS MAXIMS has announced that it has been shortlisted as a finalist in the 'Technology provider of the year' category for the HealthInvestor Awards 2013. The prestigious HealthInvestor awards recognise innovation in the healthcare sector and celebrate excellence in a wide range of categories from complex care provider of the year to diagnostics provider of the year. In each of the 22 categories an independent panel of high profile judges will look for organisations and individuals that have made an outstanding contribution to healthcare throughout 2012.

IMS MAXIMS has been shortlisted for the award after the company demonstrated numerous initiatives and partnerships aimed at improving the quality of patient care, increasing efficiency and enhancing the uptake of healthcare IT across the health service.

Among the initiatives was the launch of the Electronic Patient Information Centre (E.P.I.Centre) campaign, which aims to promote innovation across health and social care through the development of a physical and virtual centre to share best practice around healthcare technology.

In addition, IMS MAXIMS announced a 'first of its kind' partnership with St Helen’s and Knowsley Teaching Hospitals NHS Trust, to offer the NHS a fully integrated electronic patient record solution hosted within an NHS trust.

Shane Tickell, CEO of IMS MAXIMS said: "Being shortlisted as a finalist in the 'Technology provider of the year' category is testament to the hard work of the IMS MAXIMS team in thinking outside the box to deliver agile solutions that meet the needs of the healthcare service.

"IMS MAXIMS prides itself on its responsiveness and ability to tailor its solutions to the individual needs of healthcare organisations as well as having a deep understanding of how technology can help address much wider issues. We very much look forward to the awards ceremony in June."

During 2012, IMS MAXIMS also began the development of its Da Vinci product, a cloud-based electronic health record for patients that will be supplemented by a number of mobile apps to give patients ownership and responsibility for their health record, potentially removing the need for hospitals to store such information on their own systems. IMS MAXIMS' innovative nature has been well recognised by a number of multinational corporations, recently resulting in securing a partnership with a global IT vendor.

Other key highlights include deploying full electronic patient record system to local charity, CancerCare, to support its staff and patients, as well as working alongside an NHS hospital trust to deploy the dementia system in order to help the trust diagnose and more efficiently treat patients with dementia, meanwhile meeting CQUIN requirements and payments.

The winners of the HealthInvestor Awards will be announced at a black-tie dinner at the Grosvenor House Hotel, Park Lane, London on Wednesday 12 June.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...